<SEC-DOCUMENT>0001193125-15-310028.txt : 20150902
<SEC-HEADER>0001193125-15-310028.hdr.sgml : 20150902
<ACCEPTANCE-DATETIME>20150902083936
ACCESSION NUMBER:		0001193125-15-310028
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20150902
DATE AS OF CHANGE:		20150902

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOSCIENCE, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-205414
		FILM NUMBER:		151088549

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 200
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 200
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d48741d424b3.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT NO. 1 DATED SEPTEMBER 2, 2015
<TEXT>
<HTML><HEAD>
<TITLE>Prospectus Supplement No. 1 dated September 2, 2015</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prospectus Supplement filed pursuant to Rule 424(b)(3) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in connection with Registration Statement No.&nbsp;333-205414 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Aytu BioScience, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Prospectus Supplement No.&nbsp;1 dated September&nbsp;2, 2015 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(to Prospectus dated August&nbsp;10, 2015) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2,564,872 shares of common stock </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement supplements information contained in that certain prospectus dated August&nbsp;10, 2015, relating to the offer and
sale by the selling stockholders listed in the prospectus of up to 2,564,872 shares of common stock of Aytu BioScience, Inc. This prospectus supplement is not complete without, and may not be delivered or used except in connection with, the original
prospectus. We will not receive any proceeds from the sale of the shares of common stock by selling stockholders. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Material Information
Reported in Current Report on Form 8-K </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;1, 2015, we closed on the sale of convertible promissory notes with an
aggregate principal amount of $2.0 million and filed a Current Report on Form 8-K on September&nbsp;2, 2015 to report the closing. The material portions of that Form 8-K are set forth below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;31, 2015, we entered into note purchase agreements with institutional and high net worth individual investors
for the purchase and sale of convertible promissory notes with an aggregate principal amount of $2,000,000. The sale of the notes closed on September&nbsp;1, 2015, and was the third and final closing of a private placement pursuant to which we
raised an aggregate of $5,175,000 from the sale of notes. As previously reported, on July&nbsp;22 and August&nbsp;11, 2015, we sold an aggregate of $3,175,000 of notes. A description of the notes is set forth in Item&nbsp;2.03 hereof. A copy of the
press announcing the final closing is attached hereto as Exhibit 99.1. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Newbridge Securities Corporation, Member
FINRA/SIPC, through LifeTech Capital, acted as sole placement agent for the institutional portion of the offering. We sold the balance of the notes to individuals and entities with whom we have an established relationship. For notes sold by the
placement agent, we paid the placement agent 8% of the gross proceeds of notes sold by the placement agent and a warrant to purchase shares of our common stock equal to 8% of the gross proceeds of the notes sold by the placement agent divided by the
price per share at which equity securities are sold in our next equity financing. The placement agent warrant has a term of five years, will have an exercise price equal to 100% of the price per share at which equity securities are sold in our next
equity financing, and provides for cashless exercise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds of the offering to conduct
clinical studies for both Zertane<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and RedoxSYS&#153; and for working capital to begin commercializing FDA-approved ProstaScint<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, as
well as general corporate purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to file a registration statement on Form S-1 within five months of the
closing registering all of the shares underlying the notes sold in the offering and to use our best efforts to have the registration statement declared effective by the Securities and Exchange Commission within 12 months of the initial closing,
which was on July&nbsp;22, 2015. The registration statement will register a number of shares of the our common stock equal to our best estimate of the number of shares into which all of the notes sold in the offering will be convertible (based upon
120% of principal, 120% of one year interest and using a conversion price of $4.63 per share). </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A description of the notes is contained in the original prospectus under the heading of &#147;Prospectus Summary &#150; Recent
Developments.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Investing in our common stock involves a high degree of risk. See &#147;Risk Factors&#148; beginning on page 11 of the original prospectus.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the SEC nor any state securities commission has approved or disapproved our securities or determined that this prospectus
is truthful or complete. It is illegal for anyone to tell you otherwise. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The date of this Prospectus Supplement No.&nbsp;1 is
September&nbsp;2, 2015. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
